AT411021T - Bridged piperidine derivatives as melanocortin receptor agonists - Google Patents

Bridged piperidine derivatives as melanocortin receptor agonists

Info

Publication number
AT411021T
AT411021T AT02750014T AT02750014T AT411021T AT 411021 T AT411021 T AT 411021T AT 02750014 T AT02750014 T AT 02750014T AT 02750014 T AT02750014 T AT 02750014T AT 411021 T AT411021 T AT 411021T
Authority
AT
Austria
Prior art keywords
receptor agonists
melanocortin receptor
piperidine derivatives
bridged piperidine
bridged
Prior art date
Application number
AT02750014T
Other languages
German (de)
Inventor
Zhixiong Ye
Khaled Barakat
Liangqin Guo
Ravi Nargund
Iyassu Sebhat
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US30635901P priority Critical
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of AT411021T publication Critical patent/AT411021T/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10Drugs for genital or sexual disorders; Contraceptives for impotence
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/06Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
AT02750014T 2001-07-18 2002-07-12 Bridged piperidine derivatives as melanocortin receptor agonists AT411021T (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US30635901P true 2001-07-18 2001-07-18

Publications (1)

Publication Number Publication Date
AT411021T true AT411021T (en) 2008-10-15

Family

ID=23184940

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02750014T AT411021T (en) 2001-07-18 2002-07-12 Bridged piperidine derivatives as melanocortin receptor agonists

Country Status (8)

Country Link
US (1) US7115628B2 (en)
EP (1) EP1411940B1 (en)
JP (1) JP4336196B2 (en)
AT (1) AT411021T (en)
AU (1) AU2002320494B2 (en)
CA (1) CA2453609C (en)
DE (1) DE60229393D1 (en)
WO (1) WO2003007949A1 (en)

Families Citing this family (83)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1571670A (en) 2001-10-20 2005-01-26 贝林格尔英格海姆法玛两合公司 Treating sexual desire disorders with flibanserin
US7105526B2 (en) 2002-06-28 2006-09-12 Banyu Pharmaceuticals Co., Ltd. Benzimidazole derivatives
EP1539744A4 (en) 2002-07-11 2007-06-06 Vicuron Pharm Inc N-hydroxyamide derivatives possessing antibacterial activity
WO2004024720A1 (en) 2002-09-11 2004-03-25 Merck & Co., Inc. Piperazine urea derivatives as melanocortin-4 receptor agonists
US7772188B2 (en) 2003-01-28 2010-08-10 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of gastrointestinal disorders
WO2004078717A1 (en) 2003-03-03 2004-09-16 Merck & Co., Inc. Acylated piperazine derivatives as melanocortin-4 receptor agonists
WO2004087159A1 (en) 2003-03-26 2004-10-14 Merck & Co., Inc. Bicyclic piperidine derivatives as melanocortin-4 receptor agonists
US7049323B2 (en) 2003-04-25 2006-05-23 Bristol-Myers Squibb Company Amidoheterocycles as modulators of the melanocortin-4 receptor
MXPA05011830A (en) 2003-05-09 2006-01-26 Novo Nordisk As Peptides for use in treating obesity.
AT547404T (en) 2003-09-22 2012-03-15 Msd Kk piperidine
MXPA06003474A (en) 2003-09-30 2006-06-05 Novo Nordisk As Melanocortin receptor agonists.
WO2005047253A1 (en) * 2003-11-12 2005-05-26 Lg Life Sciences Ltd. Melanocortin receptor agonists
EP1685102A4 (en) * 2003-11-12 2008-08-20 Lg Life Sciences Ltd Melanocortin receptor agonists
US7253283B2 (en) * 2004-01-16 2007-08-07 Bristol-Myers Squibb Company Tricyclic modulators of the glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
CA2617649A1 (en) 2005-08-11 2007-02-22 Amylin Pharmaceuticals, Inc. Hybrid polypeptides with selectable properties
EP2330125A3 (en) 2005-08-11 2012-12-12 Amylin Pharmaceuticals, Inc. Hybrid polypeptides with selectable properties
EP2305352A1 (en) 2004-04-02 2011-04-06 Merck Sharp & Dohme Corp. 5-alpha-reductase inhibitors for use in the treatment of men with metabolic and anthropometric disorders
BRPI0510074A (en) * 2004-04-22 2007-10-16 Boehringer Ingelheim Int Pharmaceutical compositions for the treatment of sexual disorders ii
CN1988906A (en) 2004-07-19 2007-06-27 默克公司 Acylated piperidine derivatives as melanocortin 4-receptor agonists
FR2873693B1 (en) * 2004-07-29 2006-09-15 Sanofi Synthelabo Amino-tropane derivatives, their preparation and their therapeutic application
FR2873690B1 (en) * 2004-07-29 2006-10-13 Sanofi Synthelabo Oxopiperidine derivatives, their preparation and their therapeutic application
US8394765B2 (en) 2004-11-01 2013-03-12 Amylin Pharmaceuticals Llc Methods of treating obesity with two different anti-obesity agents
JP4926069B2 (en) 2004-11-01 2012-05-09 アミリン・ファーマシューティカルズ,インコーポレイテッドAmylin Pharmaceuticals, Inc. Methods for treating obesity and obesity-related diseases and disorders
WO2006129826A1 (en) 2005-05-30 2006-12-07 Banyu Pharmaceutical Co., Ltd. Novel piperidine derivative
US20070021433A1 (en) 2005-06-03 2007-01-25 Jian-Qiang Fan Pharmacological chaperones for treating obesity
US20080167488A1 (en) * 2005-07-29 2008-07-10 Astrazeneca Ab Process for the Preparation of Geminal ((Difluorocycloalkyl)Methyl) Amines
WO2007014929A1 (en) 2005-08-03 2007-02-08 Boehringer Ingelheim International Gmbh Use of flibanserin in the treatment of obesity
US20100216758A1 (en) 2005-08-10 2010-08-26 Makoto Ando Pyridone Compounds
DE602006017712D1 (en) 2005-08-24 2010-12-02 Banyu Pharma Co Ltd Phenylpyridonderivat
JP4723320B2 (en) * 2005-09-05 2011-07-13 明治飼糧株式会社 Blood leptin level increasing agent
WO2007029847A1 (en) 2005-09-07 2007-03-15 Banyu Pharmaceutical Co., Ltd. Bicyclic aromatic substituted pyridone derivative
BRPI0616463A2 (en) 2005-09-29 2011-06-21 Merck & Co Inc compound, pharmaceutical composition, and use of a compound
EP1940401B1 (en) 2005-10-18 2012-07-11 Merck Sharp & Dohme Corp. Acylated spiropiperidine derivatives as melanocortin-4 receptor modulators
US20080255084A1 (en) 2005-10-21 2008-10-16 Randy Lee Webb Combination of Organic Compounds
JPWO2007049798A1 (en) 2005-10-27 2009-04-30 萬有製薬株式会社 New benzooxathiin derivatives
WO2007048803A1 (en) 2005-10-29 2007-05-03 Boehringer Ingelheim International Gmbh Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders
MY146564A (en) 2005-11-10 2012-08-30 Msd Kk Aza-substituted spiro derivatives
US7601844B2 (en) 2006-01-27 2009-10-13 Bristol-Myers Squibb Company Piperidinyl derivatives as modulators of chemokine receptor activity
US7615556B2 (en) 2006-01-27 2009-11-10 Bristol-Myers Squibb Company Piperazinyl derivatives as modulators of chemokine receptor activity
WO2008000760A1 (en) 2006-06-30 2008-01-03 Boehringer Ingelheim International Gmbh Flibanserin for the treatment of urinary incontinence and related diseases
TWI332501B (en) 2006-07-14 2010-11-01 Lg Life Sciences Ltd Melanocortin receptor agonists
MX2009001551A (en) 2006-08-14 2009-02-20 Boehringer Ingelheim Int Formulations of flibanserin and method for manufacturing the same.
EP2056797A2 (en) 2006-08-25 2009-05-13 Boehringer Ingelheim International GmbH Controlled release system and method for manufacturing the same
EP2698157B1 (en) 2006-09-22 2015-05-20 Merck Sharp & Dohme Corp. Method of treatment using fatty acid synthesis inhibitors
CA2664358A1 (en) 2006-09-28 2008-04-03 Banyu Pharmaceutical Co., Ltd. Diarylketimine derivative
CA2672957C (en) 2006-12-20 2015-04-14 Boehringer Ingelheim International Gmbh Sulfated benzimidazolone derivatives having mixed serotonine receptor affinity
WO2008120653A1 (en) 2007-04-02 2008-10-09 Banyu Pharmaceutical Co., Ltd. Indoledione derivative
CA2688161A1 (en) 2007-06-04 2008-12-11 Kunwar Shailubhai Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
US8969514B2 (en) 2007-06-04 2015-03-03 Synergy Pharmaceuticals, Inc. Agonists of guanylate cyclase useful for the treatment of hypercholesterolemia, atherosclerosis, coronary heart disease, gallstone, obesity and other cardiovascular diseases
UY31335A1 (en) 2007-09-12 2009-04-30 Treatment of vasomotor symptoms
EP2264026A4 (en) 2008-03-06 2012-03-28 Msd Kk Alkylaminopyridine derivative
EP2272841A1 (en) 2008-03-28 2011-01-12 Banyu Pharmaceutical Co., Ltd. Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor
EP3239170B1 (en) 2008-06-04 2019-03-20 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders
CA2727914A1 (en) 2008-06-19 2009-12-23 Banyu Pharmaceutical Co., Ltd. Spirodiamine-diaryl ketoxime derivative technical field
TWI433838B (en) 2008-06-25 2014-04-11 Squibb Bristol Myers Co Piperidinyl derivative as a modulator of chemokine receptor activity
EP2321341B1 (en) 2008-07-16 2017-02-22 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase useful for the treatment of gastrointestinal, inflammation, cancer and other disorders
US20110124674A1 (en) 2008-07-30 2011-05-26 Hiroyuki Kishino 5/5-or 5/6-membered condensed ring cycloalkylamine derivative
US8410284B2 (en) 2008-10-22 2013-04-02 Merck Sharp & Dohme Corp Cyclic benzimidazole derivatives useful as anti-diabetic agents
EP2362731B1 (en) 2008-10-31 2016-04-06 Merck Sharp & Dohme Corp. Novel cyclic benzimidazole derivatives useful anti-diabetic agents
FR2937973B1 (en) * 2008-11-04 2010-11-05 Galderma Res & Dev Melanocortin receptor modulators, process for their preparation and their use in human medicine and cosmetics
WO2010056717A1 (en) 2008-11-17 2010-05-20 Merck Sharp & Dohme Corp. Substituted bicyclic amines for the treatment of diabetes
WO2011011506A1 (en) 2009-07-23 2011-01-27 Schering Corporation Spirocyclic oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
US20120220567A1 (en) 2009-07-23 2012-08-30 Shipps Jr Gerald W Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitors
US8476227B2 (en) 2010-01-22 2013-07-02 Ethicon Endo-Surgery, Inc. Methods of activating a melanocortin-4 receptor pathway in obese subjects
US9044606B2 (en) 2010-01-22 2015-06-02 Ethicon Endo-Surgery, Inc. Methods and devices for activating brown adipose tissue using electrical energy
JP2013520502A (en) 2010-02-25 2013-06-06 メルク・シャープ・エンド・ドーム・コーポレイション Novel cyclic benzimidazole derivatives that are useful anti-diabetic drugs
WO2011104378A1 (en) 2010-02-26 2011-09-01 Novo Nordisk A/S Peptides for treatment of obesity
BR112012021231A2 (en) 2010-02-26 2015-09-08 Basf Plant Science Co Gmbh method for enhancing plant yield, plant, construct, use of a construct, method for producing a transgenic plant, collectable parts of a plant, products derived from a plant, use of a nucleic acid and method for producing a product
WO2011137024A1 (en) 2010-04-26 2011-11-03 Merck Sharp & Dohme Corp. Novel spiropiperidine prolylcarboxypeptidase inhibitors
EP2568812B1 (en) 2010-05-11 2016-10-26 Merck Sharp & Dohme Corp. Novel prolylcarboxypeptidase inhibitors
EP2579873A4 (en) 2010-06-11 2013-11-27 Merck Sharp & Dohme Novel prolylcarboxypeptidase inhibitors
US8642622B2 (en) 2010-06-16 2014-02-04 Bristol-Myers Squibb Company Piperidinyl compound as a modulator of chemokine receptor activity
US9616097B2 (en) 2010-09-15 2017-04-11 Synergy Pharmaceuticals, Inc. Formulations of guanylate cyclase C agonists and methods of use
US9018395B2 (en) 2011-01-27 2015-04-28 Université de Montréal Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
MX348131B (en) 2011-02-25 2017-05-26 Merck Sharp & Dohme Novel cyclic azabenzimidazole derivatives useful as anti-diabetic agents.
KR20150036245A (en) 2012-08-02 2015-04-07 머크 샤프 앤드 돔 코포레이션 Antidiabetic tricyclic compounds
JP2016514670A (en) 2013-03-15 2016-05-23 シナジー ファーマシューティカルズ インコーポレイテッド Guanylate cyclase receptor agonists in combination with other drugs
AU2014235215A1 (en) 2013-03-15 2015-10-01 Synergy Pharmaceuticals Inc. Agonists of guanylate cyclase and their uses
JP6606491B2 (en) 2013-06-05 2019-11-13 シナジー ファーマシューティカルズ インコーポレイテッド Ultra high purity agonist of guanylate cyclase C, method for producing and using the same
MX2017002610A (en) 2014-08-29 2017-10-11 Tes Pharma S R L INHIBITORS OF A-AMINO-ß-CARBOXYMUCONIC ACID SEMIALDEHYDE DECARBOXYLASE.
US10092738B2 (en) 2014-12-29 2018-10-09 Ethicon Llc Methods and devices for inhibiting nerves when activating brown adipose tissue
US10080884B2 (en) 2014-12-29 2018-09-25 Ethicon Llc Methods and devices for activating brown adipose tissue using electrical energy
WO2018069532A1 (en) 2016-10-14 2018-04-19 Tes Pharma S.R.L. Inhibitors of alpha-amino-beta-carboxymuconic acid semialdehyde decarboxylase

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1115817A (en) * 1965-08-23 1968-05-29 Loevens Kemiske Fab 2-aza-bicyclo[2,2,2]octanones and compositions containing them
WO1992019595A1 (en) * 1991-05-07 1992-11-12 Merck & Co., Inc. Fibrinogen receptor antagonists
JP3204510B2 (en) 1993-04-05 2001-09-04 コンペティティブ テクノロジーズ,インク. Diagnosis and treatment of erectile dysfunction
US5721251A (en) * 1993-12-10 1998-02-24 Merck & Co., Inc. Piperidine, pyrrolidine and hexahydro-1H-azepines promote release of growth hormone
US6166037A (en) 1997-08-28 2000-12-26 Merck & Co., Inc. Pyrrolidine and piperidine modulators of chemokine receptor activity
EP1009405A4 (en) 1997-08-28 2001-05-09 Merck & Co Inc Pyrrolidine and piperidine modulators of chemokine receptor activity
AU742425B2 (en) 1998-06-11 2002-01-03 Merck & Co., Inc. Spiropiperidine derivatives as melanocortin receptor agonists
CA2362918A1 (en) * 1999-03-08 2000-09-14 Joanne Waldstreicher Methods and compositions for treating erectile dysfunction
EP1187611B1 (en) 1999-06-03 2004-08-18 Maxim Pharmaceuticals, Inc. Ophthalmic histamine compositions and uses thereof
CA2377369A1 (en) 1999-06-04 2000-12-14 Merck & Co., Inc. Substituted piperidines as melanocortin-4 receptor agonists
KR20020073586A (en) 2000-02-11 2002-09-27 버텍스 파마슈티칼스 인코포레이티드 Piperazine and piperidine derivatives
AU4929601A (en) * 2000-03-23 2001-10-03 Merck & Co Inc Substituted piperidines as melanocortin receptor agonists
EP1268000A4 (en) 2000-03-23 2004-12-29 Merck & Co Inc Spiropiperidine derivatives as melanocortin receptor agonists
JP2003534377A (en) 2000-05-30 2003-11-18 メルク エンド カムパニー インコーポレーテッド Melanocortin receptor agonist
US6960597B2 (en) 2000-06-30 2005-11-01 Orth-Mcneil Pharmaceutical, Inc. Aza-bridged-bicyclic amino acid derivatives as α4 integrin antagonists
BR0207658A (en) 2001-02-28 2005-10-25 Merck & Co Inc Methods for treating or preventing disorders, diseases or conditions responsive to melanocortin-4 receptor activation, obesity, diabetes mellitus, male or female sexual dysfunction, and erectile dysfunction in a mammal in need thereof, and, pharmaceutical composition
AU2002255597B8 (en) 2001-02-28 2006-10-26 Merck Sharp & Dohme Corp. Acylated piperidine derivatives as melanocortin-4 receptor agonists
DE60232238D1 (en) 2001-02-28 2009-06-18 Merck & Co Inc Acylated piperidine derivatives than melanocortin-4-receptor agonists
US6977264B2 (en) 2001-07-25 2005-12-20 Amgen Inc. Substituted piperidines and methods of use

Also Published As

Publication number Publication date
US7115628B2 (en) 2006-10-03
DE60229393D1 (en) 2008-11-27
EP1411940A1 (en) 2004-04-28
US20040180923A1 (en) 2004-09-16
JP2004538281A (en) 2004-12-24
EP1411940A4 (en) 2005-03-09
CA2453609C (en) 2010-05-04
AU2002320494B2 (en) 2006-06-29
EP1411940B1 (en) 2008-10-15
WO2003007949A1 (en) 2003-01-30
JP4336196B2 (en) 2009-09-30
CA2453609A1 (en) 2003-01-30

Similar Documents

Publication Publication Date Title
HRP20150371T1 (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives
RU2414469C3 (en) New oxazolidinon derivatives
DE60214428D1 (en) 1, 4-dihydro-1, 4-diphenylpyridine derivatives
DE50210090D1 (en) Substituted phenyl derivatives
DE60120748D1 (en) 3-substituted oxindole derivatives as beta-3 agonists
DE50107560D1 (en) Mounting bracket for rails
DE60044382D1 (en) NPYY5 antagonists
DE60211223D1 (en) Piperidine derivatives as potassium channel blockers
DE50210707D1 (en) Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
DK1594840T3 (en) Piperidine-benzenesulfonamide derivatives
DK1412328T3 (en) Dolastatin-10 derivatives
DE60142355D1 (en) Piperazinylpyrazin compounds as agonists or antagonists on the serotonin 5ht-2 receptor
DE50008048D1 (en) Mounting element, especially for furniture construction
DE50010931D1 (en) Substituted benzimidazole
DE60328925D1 (en) jitter
DE60305724D1 (en) Tetrahydrochinolin derivatives than crth2 antagonists
DK1749818T3 (en) Phenylpiperidine derivatives as serotonin reuptake inhibitors
DE60216115D1 (en) BENZIMIDAZO 4,5-föISOCHINOLINONE DERIVATIVES
DE60324544D1 (en) Muscarin antagonists
EP1289526A4 (en) Melanocortin receptor agonists
DE60217147D1 (en) Lactam derivatives for use as humane 11cby receptor antagonists
ZA200409339B (en) Novel benzimidazole derivatives.
AU2002258414A1 (en) Acylated Piperidine Derivatives as Melanocortin-4 Receptor Agonists
AU2002250343A1 (en) Acylated piperidine derivatives as melanocortin-4 receptor agonists
DE60228229D1 (en) New adenine derivatives

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties